These data include the original data of in vitro and in vivo experiments. "P VS PR" means: comparing results between GEM-resistant pancreatic cancer cells and their parental sensitive ones. "TOTAL" me
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers with no targeted or personalized therapeutics. PDAC cells reprogram their transcriptional and metabolic state to sustain th
The development of clinical stroke therapies remains elusive. The neuroprotective efficacies of thousands of molecules and compounds have not yet been determined; however, screening large volumes of p
